These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15711432

  • 1. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study.
    Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M.
    Clin Neuropharmacol; 2005; 28(1):6-10. PubMed ID: 15711432
    [Abstract] [Full Text] [Related]

  • 2. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.
    Dannon PN, Lowengrub K, Musin E, Gonopolski Y, Kotler M.
    J Clin Psychopharmacol; 2005 Dec; 25(6):593-6. PubMed ID: 16282845
    [Abstract] [Full Text] [Related]

  • 3. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study.
    Dannon PN, Lowengrub K, Musin E, Gonopolsky Y, Kotler M.
    J Clin Psychopharmacol; 2007 Dec; 27(6):620-4. PubMed ID: 18004130
    [Abstract] [Full Text] [Related]

  • 4. Short-term single-blind fluvoxamine treatment of pathological gambling.
    Hollander E, DeCaria CM, Mari E, Wong CM, Mosovich S, Grossman R, Begaz T.
    Am J Psychiatry; 1998 Dec; 155(12):1781-3. PubMed ID: 9842795
    [Abstract] [Full Text] [Related]

  • 5. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS).
    Pallanti S, DeCaria CM, Grant JE, Urpe M, Hollander E.
    J Gambl Stud; 2005 Dec; 21(4):431-43. PubMed ID: 16311876
    [Abstract] [Full Text] [Related]

  • 6. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
    Pallanti S, Baldini Rossi N, Sood E, Hollander E.
    J Clin Psychiatry; 2002 Nov; 63(11):1034-9. PubMed ID: 12444818
    [Abstract] [Full Text] [Related]

  • 7. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling.
    Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C.
    Biol Psychiatry; 2000 May 01; 47(9):813-7. PubMed ID: 10812040
    [Abstract] [Full Text] [Related]

  • 8. Dual psychiatric diagnosis and substance abuse in pathological gamblers: a preliminary gender comparison study.
    Dannon PN, Lowengrub K, Shalgi B, Sasson M, Tuson L, Saphir Y, Kotler M.
    J Addict Dis; 2006 May 01; 25(3):49-54. PubMed ID: 16956869
    [Abstract] [Full Text] [Related]

  • 9. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
    Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N.
    Am J Psychiatry; 2005 Jan 01; 162(1):137-45. PubMed ID: 15625212
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled trial of topiramate for pathological gambling.
    Berlin HA, Braun A, Simeon D, Koran LM, Potenza MN, McElroy SL, Fong T, Pallanti S, Hollander E.
    World J Biol Psychiatry; 2013 Mar 01; 14(2):121-8. PubMed ID: 21486110
    [Abstract] [Full Text] [Related]

  • 11. Pathological gambling: comorbid psychiatric diagnoses in patients and their families.
    Dannon PN, Lowengrub K, Aizer A, Kotler M.
    Isr J Psychiatry Relat Sci; 2006 Mar 01; 43(2):88-92. PubMed ID: 16910370
    [Abstract] [Full Text] [Related]

  • 12. A pilot placebo-controlled study of fluvoxamine for pathological gambling.
    Blanco C, Petkova E, Ibáñez A, Sáiz-Ruiz J.
    Ann Clin Psychiatry; 2002 Mar 01; 14(1):9-15. PubMed ID: 12046642
    [Abstract] [Full Text] [Related]

  • 13. Use of Topiramate in Skin-Picking Disorder: A Pilot Study.
    Jafferany M, Osuagwu FC.
    Prim Care Companion CNS Disord; 2017 Jan 26; 19(1):. PubMed ID: 28129492
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
    Grant JE, Kim SW, Hartman BK.
    J Clin Psychiatry; 2008 May 26; 69(5):783-9. PubMed ID: 18384246
    [Abstract] [Full Text] [Related]

  • 15. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
    Kim SW, Grant JE, Adson DE, Shin YC.
    Biol Psychiatry; 2001 Jun 01; 49(11):914-21. PubMed ID: 11377409
    [Abstract] [Full Text] [Related]

  • 16. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
    Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A.
    Am J Psychiatry; 2006 Feb 01; 163(2):303-12. PubMed ID: 16449486
    [Abstract] [Full Text] [Related]

  • 17. An open-label trial of escitalopram in the treatment of pathological gambling.
    Black DW, Shaw M, Forbush KT, Allen J.
    Clin Neuropharmacol; 2007 Feb 01; 30(4):206-12. PubMed ID: 17762317
    [Abstract] [Full Text] [Related]

  • 18. Comorbidity of impulse control disorders in pathological gamblers.
    Grant JE, Kim SW.
    Acta Psychiatr Scand; 2003 Sep 01; 108(3):203-7. PubMed ID: 12890275
    [Abstract] [Full Text] [Related]

  • 19. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul 01; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

  • 20. Lithium and valproate treatment of pathological gambling: a randomized single-blind study.
    Pallanti S, Quercioli L, Sood E, Hollander E.
    J Clin Psychiatry; 2002 Jul 01; 63(7):559-64. PubMed ID: 12143910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.